Latest

The Regulation of Social Media – Not as easy as it sounds…

The Biden administration in Washington and the European Commission in Brussels have vowed to regulate social media more robustly. But…

Eco Animal Health’s half year results impress investors

Eco Animal Health has seen its share price surge after reporting quadrupled pre-tax profits for the six months ended 30th…

Unilever sinks after 2020 washout

Shares in FTSE 100 consumer goods giant Unilever have dropped by 3.74% after reporting a 4.6% decline in operating profits…

Stocks in Focus: Sareum Holdings

A developer of best-in-class targeted therapeutics has had its near- clinic ready TYK2/JAK 1 inhibitor programme earmarked as a potential…

The Vaccinators – Some vaccine developers have fared better than others

Some pharmaceutical companies have managed to develop a coronavirus vaccine in record time, while others have given up.

Unite Students discount policy cause share backlash

Specialist property firm Unite Students has seen its share price drop by 5.33% after it extended its rental discount program…

Quarterly update lifts Vodafone shares

The price of shares in Vodafone has increased by 5.53% after it returned to service revenue growth during the quarter…

Are these 2 FTSE 100 shares underrated by investors?

Robert Stephens, CFA, discusses why two FTSE 100 stocks with defensive credentials may be more attractive than their recent share…

Ebiquity – I hope that I have got it right this time

Mark Watson-Mitchell takes another look at the data-based marketing consultant after a disappointing performance over the last year.

Evil Diaries: Anything but Clear

Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.